Astrid Lipplaa

Novel Δ⁹‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

Linda E. Klumpers, Tim L. Beumer, J. G. Coen van Hasselt et al. · British Journal of Clinical Pharmacology · 2012 · 77 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series

Astrid Lipplaa, Hans Gelderblom · Clinical Sarcoma Research · 2016 · 28 citations · Full text

Medicine, Oncology, Pharmacology +14

Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial

Astrid Lipplaa, Judith R. Kroep, L. van der Heijden et al. · The Oncologist · 2019 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial

Astrid Lipplaa, Ricardo Fernandes, Andrea Marshall et al. · British Journal of Cancer · 2018 · 16 citations · Full text

Medicine, Oncology, Neoplasia +14

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis

Willem H. Schreuder, Astrid Lipplaa, Arjen H.G. Cleven et al. · European Journal of Cancer · 2022 · 14 citations · Full text

Medicine, Oncology, Maxillofacial Pathology +12